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Purpose or Objective
Despite high local control in patients with hepatocellular
carcinoma (HCC) who receive liver stereotactic body
radiotherapy (SBRT), locoregional control (LRC) remains
dismal and is associated with long-term failures and poor
survival. The purpose of the current study is to evaluate
deep learning models for predicting LRC and
personalization of HCC treatment.
Material and Methods
Data from 146 HCC patients who received SBRT from 2005-
14 were analyzed retrospectively. Tumor doses (median
prescribed = 49.8 Gy, delivered in 3 or 5 fractions) were
bio-corrected to 2 Gy equivalents. Patient demographics
(age, sex, stage, etc) dosimetric (dose-volume metrics of
tumor and surrounding normal tissue), and toxicity
information ((ALBI, Child-Pugh, enzymatic changes) were
extracted from the patients’ records. Despite local
control of greater than 90%, the locoregional failure rate
was 54.7% with a median follow-up of 11 months.
Predictive models based on deep machine learning
techniques for predicting LRC were developed using the
open source neural network library (Keras). The deep
learning network architectures included dense and
dropout layers with ReLu activation functions. The loss
function was defined in terms of cross-entropy and the
weights for the network were estimated using an adaptive
stochastic gradient algorithm (Adam). These models were
compared with traditional statistical techniques based on
variable shrinkage analysis with logistic regression (Lasso-
logistic). The data were normalized using z-scoring (mean-
centered) prior to modeling. To avoid overfitting pitfalls,
10-fold cross-validation resampling was used to evaluate
prediction, and performance was assessed using the area
under the receiver-operating characteristics curve (AUC).
Results
When modeling with Lasso-logistic regression the
predictive LRC achieved an AUC = 0.57 on cross-validation
with functional toxicity (ALBI) as the highest
contributor. When deep learning was applied, the
prediction of LRC improved by 17.5%, and the prediction
of the algorithm reached an AUC = 0.67 on cross-
validation. The performance seemed to be affected by
the dropout layer rates, which act as a regularization
process to prevent neural network overfitting, with a 
dropout rate of 20% providing stable results.
Conclusion
Machine learning methods based on deep learning can
provide a robust framework for estimating locoregional
failure risk in HCC patients post-SBRT. However, proper
tuning of parameters is necessary to avoid overfitting and
evaluation on independent data is needed to further
assess generalizability. These new LRC models show
promise for personalizing new regimens for combining
local and systemic therapy in HCC patients.
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Purpose or Objective
The objective of this study was to evaluate the usefulness
of radiomics for predicting locoregional relapse in head
and neck cancer patients using PET/CT images.
Material and Methods
This retrospective study includes 182 head and neck
cancer patients, who underwent a combined 18F-FDG-
PET/CT scan prior to radiotherapy. Patients were divided
into two classes according to locoregional control; 47 with
failures and 135 with control. The radiomics approach was
used to extract features characterizing the primary
tumour from both PET and CT images. First order
statistical features such as median values and
interquartile range, shape features including sphericity
and tumour surface area as well as texture features
describing intensity non-uniformity, busyness and
coarseness were calculated. Features were also calculated
from PET and CT images transformed using point and two-
dimensional transformations to emphasize particular
aspects of the tumour. Clinical factors (age, sex, ECOG
status, Charlson comorbidity status, HPV-status, TNM
stage, pack years of smoking, days on the hypoxic
radiosensitizer nimorazole and number of weekly cisplatin
doses) were also included as features. Seven feature
selection methods were tested to select the most relevant
features for classification among the more than 2 500
features. Classification of the patients according to
outcome was performed using 14 different algorithms. The 
performance measure ROC-AUC (Receiver Operating
Characteristics - Area Under the Curve) of the
classification models was estimated using nested cross-
validation and was used to assess and compare the models.
Results
The classification models with the highest performance
gave a mean AUC of 0.66 ± 0.10. The models were
obtained using ReliefF for feature selection and either
Partial Least Squares Regression (PLSR), logistic
regression, Linear Discriminant Analysis (LDA) or AdaBoost
as classifiers (Figure 1). These models were based on
tumour shape and heterogeneity features such as
busyness, which characterises rapid intensity changes
between neighbouring voxels within the tumour.
Interestingly, the feature selection methods consistently
chose image features over clinical factors when these
were included in the same classification. Classification
models based solely on clinical factors gave poorer
performance with a mean AUC of 0.57 ± 0.10.
Conclusion
Characteristics of primary head and neck tumours
extracted from PET and CT images were better predictors
of treatment outcome than clinical factors alone.
Particularly tumour shape and tumour heterogeneity were
selected as relevant features for treatment outcome
prediction. Future efforts should be directed at improving
classification performance by exploring other feature
engineering and feature selection approaches.
PO-0968 Prostate-specific phantom for radiomic
features quality assurance
S. Osman1,2, E. Russell1, R.B. King2, A.J. Cole1,3, C. 
McGrath4, S. Jain1,3, A.R. Hounsell1,2, K.M. Prise1, C.K.
McGarry1,2
1Queen's University Belfast, Centre for Cancer Research
S527   ESTRO 38 
PO-0969  Sensitivity analysis of an in silico model of 
prostate tumour growth and response to radiotherapy 
C. Sosa marrero1, Ó. Acosta1, M. Castro1, A. Hernández1, 
N. Rioux-Leclercq1, R. Mathieu1, F. Paris2, R. De 
Crevoisier1 
1Univ Rennes-CHU Rennes-CLCC Eugène Marquis-INSERM, 
Ltsi - UMR 1099- F-35000, Rennes, France ; 2Université de 
Nantes, Crcina, Nantes, France  
Purpose or Objective 
In silico models are appealing tools to understand and 
predict tumour growth and response to RT. A major issue 
of computational models is the large number of variables 
they may contain. The objective of this work was to 
perform a Morris sensitivity analysis on a prostate tumour 
growth and response to RT model, to identify the most 
relevant parameters and determine which ones can be 
negligible 
Material and Methods 
Histopathological specimens from 7 patients with 
localized prostate cancer, treated with radical 
prostatectomy, were used to initialise 21 computational 
tissues with different tumour and vascular densities. 
Tumour foci were delineated by a pathologist on the HES 
axial slides (figure 1.a) and a CD31 staining (figure 1.b) 
was carried out to identify the blood vessels. A multi-scale 
in silico model was generated, considering the prostate 
computational tissues, where each voxel corresponded to 
a cell of the following 7 types: healthy 
glandular/endothelial, tumour glandular/neo-created 
endothelial and dead (by apoptosis, hypoxic necrosis or 
mitotic catastrophe). Figure 1.c shows the corresponding 
initial computational tissue. The model integrated 5 
biological processes: oxygenation of the tissue (Oxy.) using 
a reaction-diffusion equation (Espinoza et al., Med Phys 
2013); proliferation of tumour cells, considering their life-
cycle (Prolif.); angiogenesis based on the VEGF diffusion 
(Angio.) (Harting et al., Phys. Med. Bio 2007); phase-and-
oxygen-dependent response to irradiation, using the 
linear-quadratic model and considering cycle arrests and 
death by mitotic catastrophe (RespToIrr.) and resorption 
of dead cells (Resor). The table presents the 34 
parameters of the model, indicating the process they 
intervene in. Every simulation considered a total dose of 
80 Gy, administered every 24 h, from Monday to Friday. 
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Figure 1.d shows the computational prostate tissue after 
80 Gy. The tumour density (number of tumour cells 
divided by the total number of cells) at the end of the 
treatment was used as output of the model. The Morris 
sensitivity method calculated, on the 21 computational 
tissues (73500 simulations in total), the mean and 
standard values (μi* ± σi) of 100 elementary effects for 
each parameter. The Euclidean distance of the point (μi*, 
σi) to the origin was the indicator of the impact of 
parameter i. 
Results 
The table shows a ranking of the 34 parameters of the 
model, according to their mean Euclidean distances over 
the 21 tissues. 
Table. Ranking of the 34 parameters of the model, 
according to their mean Euclidean distance to the origin 
Conclusion 
The Morris sensitivity analysis identified the duration of 
the cycle of tumour cells and the dose per fraction as the 
parameters having the greatest effect on the final tumour 
density after 80 Gy. The VEGF Michaelis-Menten maximun 
rate, the VEGF Michaelis constant and the VEGF diffusion 
coefficient had the lowest impact. 
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